Poliomyelitis Vaccine Market, Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: P41B5D265412EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Poliomyelitis Vaccine in global, including the following market information:

Global Poliomyelitis Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Poliomyelitis Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Poliomyelitis Vaccine companies in 2021 (%)

The global Poliomyelitis Vaccine market was valued at 730.3 million in 2021 and is projected to reach US$ 957.4 million by 2028, at a CAGR of 3.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Poliomyelitis Vaccine ? Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Poliomyelitis Vaccine include GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poliomyelitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Poliomyelitis Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccine Market Segment Percentages, by Type, 2021 (%)

• Poliomyelitis Vaccine ?
• Poliomyelitis Vaccine ?
• Poliomyelitis Vaccine ?
• Oral Poliomyelitis Vaccine

Global Poliomyelitis Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccine Market Segment Percentages, by Application, 2021 (%)

• VAPP
• VDPV

Global Poliomyelitis Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Poliomyelitis Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Poliomyelitis Vaccine revenues share in global market, 2021 (%)

Key companies Poliomyelitis Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Poliomyelitis Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Sanofi-Pasteur
• Merck
• Crucell
• China National Biotech Group
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Poliomyelitis Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Poliomyelitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL POLIOMYELITIS VACCINE OVERALL MARKET SIZE

2.1 Global Poliomyelitis Vaccine Market Size: 2021 VS 2028
2.2 Global Poliomyelitis Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Poliomyelitis Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Poliomyelitis Vaccine Players in Global Market
3.2 Top Global Poliomyelitis Vaccine Companies Ranked by Revenue
3.3 Global Poliomyelitis Vaccine Revenue by Companies
3.4 Global Poliomyelitis Vaccine Sales by Companies
3.5 Global Poliomyelitis Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Poliomyelitis Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Poliomyelitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliomyelitis Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Poliomyelitis Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Poliomyelitis Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Poliomyelitis Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Poliomyelitis Vaccine ?
  4.1.3 Poliomyelitis Vaccine ?
  4.1.4 Poliomyelitis Vaccine ?
  4.1.5 Oral Poliomyelitis Vaccine
4.2 By Type - Global Poliomyelitis Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Poliomyelitis Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Poliomyelitis Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Poliomyelitis Vaccine Sales & Forecasts
  4.3.1 By Type - Global Poliomyelitis Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Poliomyelitis Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Poliomyelitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Poliomyelitis Vaccine Market Size, 2021 & 2028
  5.1.2 VAPP
  5.1.3 VDPV
5.2 By Application - Global Poliomyelitis Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Poliomyelitis Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Poliomyelitis Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Poliomyelitis Vaccine Sales & Forecasts
  5.3.1 By Application - Global Poliomyelitis Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Poliomyelitis Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Poliomyelitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Poliomyelitis Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Poliomyelitis Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Poliomyelitis Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Poliomyelitis Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Poliomyelitis Vaccine Sales & Forecasts
  6.3.1 By Region - Global Poliomyelitis Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Poliomyelitis Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Poliomyelitis Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Poliomyelitis Vaccine Sales, 2017-2028
  6.4.3 US Poliomyelitis Vaccine Market Size, 2017-2028
  6.4.4 Canada Poliomyelitis Vaccine Market Size, 2017-2028
  6.4.5 Mexico Poliomyelitis Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Poliomyelitis Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Poliomyelitis Vaccine Sales, 2017-2028
  6.5.3 Germany Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.4 France Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.5 U.K. Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.6 Italy Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.7 Russia Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Poliomyelitis Vaccine Market Size, 2017-2028
  6.5.9 Benelux Poliomyelitis Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Poliomyelitis Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Poliomyelitis Vaccine Sales, 2017-2028
  6.6.3 China Poliomyelitis Vaccine Market Size, 2017-2028
  6.6.4 Japan Poliomyelitis Vaccine Market Size, 2017-2028
  6.6.5 South Korea Poliomyelitis Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Poliomyelitis Vaccine Market Size, 2017-2028
  6.6.7 India Poliomyelitis Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Poliomyelitis Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Poliomyelitis Vaccine Sales, 2017-2028
  6.7.3 Brazil Poliomyelitis Vaccine Market Size, 2017-2028
  6.7.4 Argentina Poliomyelitis Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Poliomyelitis Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Poliomyelitis Vaccine Sales, 2017-2028
  6.8.3 Turkey Poliomyelitis Vaccine Market Size, 2017-2028
  6.8.4 Israel Poliomyelitis Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Poliomyelitis Vaccine Market Size, 2017-2028
  6.8.6 UAE Poliomyelitis Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Poliomyelitis Vaccine Major Product Offerings
  7.1.4 GSK Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 GSK Key News
7.2 Sanofi-Pasteur
  7.2.1 Sanofi-Pasteur Corporate Summary
  7.2.2 Sanofi-Pasteur Business Overview
  7.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Major Product Offerings
  7.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi-Pasteur Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Poliomyelitis Vaccine Major Product Offerings
  7.3.4 Merck Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Merck Key News
7.4 Crucell
  7.4.1 Crucell Corporate Summary
  7.4.2 Crucell Business Overview
  7.4.3 Crucell Poliomyelitis Vaccine Major Product Offerings
  7.4.4 Crucell Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Crucell Key News
7.5 China National Biotech Group
  7.5.1 China National Biotech Group Corporate Summary
  7.5.2 China National Biotech Group Business Overview
  7.5.3 China National Biotech Group Poliomyelitis Vaccine Major Product Offerings
  7.5.4 China National Biotech Group Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 China National Biotech Group Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Poliomyelitis Vaccine Major Product Offerings
  7.6.4 Eli Lilly Poliomyelitis Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Eli Lilly Key News

8 GLOBAL POLIOMYELITIS VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Poliomyelitis Vaccine Production Capacity, 2017-2028
8.2 Poliomyelitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Poliomyelitis Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 POLIOMYELITIS VACCINE SUPPLY CHAIN ANALYSIS

10.1 Poliomyelitis Vaccine Industry Value Chain
10.2 Poliomyelitis Vaccine Upstream Market
10.3 Poliomyelitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Poliomyelitis Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Poliomyelitis Vaccine in Global Market
Table 2. Top Poliomyelitis Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Poliomyelitis Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Poliomyelitis Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Poliomyelitis Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Poliomyelitis Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Poliomyelitis Vaccine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Poliomyelitis Vaccine Product Type
Table 9. List of Global Tier 1 Poliomyelitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poliomyelitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Poliomyelitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Poliomyelitis Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Poliomyelitis Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Poliomyelitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Poliomyelitis Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Poliomyelitis Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Poliomyelitis Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Poliomyelitis Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Poliomyelitis Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Poliomyelitis Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Poliomyelitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Poliomyelitis Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Poliomyelitis Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Poliomyelitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Poliomyelitis Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Poliomyelitis Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Poliomyelitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Poliomyelitis Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Poliomyelitis Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Poliomyelitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Poliomyelitis Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Poliomyelitis Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Poliomyelitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Poliomyelitis Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Poliomyelitis Vaccine Sales, (K Units), 2023-2028
Table 46. GSK Corporate Summary
Table 47. GSK Poliomyelitis Vaccine Product Offerings
Table 48. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Sanofi-Pasteur Corporate Summary
Table 50. Sanofi-Pasteur Poliomyelitis Vaccine Product Offerings
Table 51. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Poliomyelitis Vaccine Product Offerings
Table 54. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Crucell Corporate Summary
Table 56. Crucell Poliomyelitis Vaccine Product Offerings
Table 57. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. China National Biotech Group Corporate Summary
Table 59. China National Biotech Group Poliomyelitis Vaccine Product Offerings
Table 60. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Eli Lilly Corporate Summary
Table 62. Eli Lilly Poliomyelitis Vaccine Product Offerings
Table 63. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Poliomyelitis Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Poliomyelitis Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Poliomyelitis Vaccine Production by Region, 2017-2022 (K Units)
Table 67. Global Poliomyelitis Vaccine Production by Region, 2023-2028 (K Units)
Table 68. Poliomyelitis Vaccine Market Opportunities & Trends in Global Market
Table 69. Poliomyelitis Vaccine Market Drivers in Global Market
Table 70. Poliomyelitis Vaccine Market Restraints in Global Market
Table 71. Poliomyelitis Vaccine Raw Materials
Table 72. Poliomyelitis Vaccine Raw Materials Suppliers in Global Market
Table 73. Typical Poliomyelitis Vaccine Downstream
Table 74. Poliomyelitis Vaccine Downstream Clients in Global Market
Table 75. Poliomyelitis Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Poliomyelitis Vaccine Segment by Type
Figure 2. Poliomyelitis Vaccine Segment by Application
Figure 3. Global Poliomyelitis Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Poliomyelitis Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Poliomyelitis Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Poliomyelitis Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliomyelitis Vaccine Revenue in 2021
Figure 9. By Type - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Poliomyelitis Vaccine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Poliomyelitis Vaccine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 19. US Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 33. China Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Poliomyelitis Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Poliomyelitis Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Poliomyelitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Poliomyelitis Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Poliomyelitis Vaccine by Region, 2021 VS 2028
Figure 50. Poliomyelitis Vaccine Industry Value Chain
Figure 51. Marketing Channels